| 000 | 01709 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516202119.0 | ||
| 264 | 0 | _c20141030 | |
| 008 | 201410s 0 0 eng d | ||
| 022 | _a1540-1413 | ||
| 024 | 7 |
_a10.6004/jnccn.2014.0034 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCleary, James M | |
| 245 | 0 | 0 |
_aCrizotinib as salvage and maintenance with allogeneic stem cell transplantation for refractory anaplastic large cell lymphoma. _h[electronic resource] |
| 260 |
_bJournal of the National Comprehensive Cancer Network : JNCCN _cMar 2014 |
||
| 300 |
_a323-6; quiz 326 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aCrizotinib |
| 650 | 0 | 4 | _aHematopoietic Stem Cell Transplantation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma, Large-Cell, Anaplastic _xdiagnosis |
| 650 | 0 | 4 | _aMaintenance Chemotherapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPositron-Emission Tomography |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aPyrazoles _xtherapeutic use |
| 650 | 0 | 4 |
_aPyridines _xtherapeutic use |
| 650 | 0 | 4 | _aSalvage Therapy |
| 650 | 0 | 4 | _aTomography, X-Ray Computed |
| 650 | 0 | 4 | _aTransplantation, Homologous |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aRodig, Scott | |
| 700 | 1 | _aBarr, Paul M | |
| 700 | 1 | _aShinagare, Atul B | |
| 700 | 1 | _aClark, Jeffrey W | |
| 700 | 1 | _aShapiro, Geoffrey I | |
| 700 | 1 | _aArmand, Philippe | |
| 773 | 0 |
_tJournal of the National Comprehensive Cancer Network : JNCCN _gvol. 12 _gno. 3 _gp. 323-6; quiz 326 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.6004/jnccn.2014.0034 _zAvailable from publisher's website |
| 999 |
_c23628479 _d23628479 |
||